Business
CSL (ASX:CSL) share price remains near 52-week low on COVID-19 vaccine delays
The CSL Limited (ASX: CSL) share price is failing to make a meaningful comeback after spending months moving sideways. The global biotech’s shares finished yesterday market session at $263.60, just 8% above its 52-week low reached in early March. At the time of writing, the CSL share price is up slightly, trading for $263.69.
Below, we take a closer look at what could be weighing down CSL shares.
COVID-19 vaccine delay
While most of the world looks towards advancing past the COVID-19 pandemic, Australia has been locked in vaccine holdups. This comes after a reported 2.5 million AstraZeneca doses are being kept in cold storage…
-
Noosa News15 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
General21 hours agoBoy dies after being trapped between rocks off NSW beach
-
Noosa News22 hours agoFarmer Fred Perry’s 30-year conservation project creates bird haven after years of ‘bashing and burning’
-
Noosa News22 hours agoDetectives continue to search for answers on Crystal Beale’s death